Table 2.
Treatment Group | Tumor Cells | Endothelial Cells | |||
PCNA* | TUNEL* | CD31* | TUNEL+ (%)† | ||
Mean | Range | ||||
Control | 488 ± 59 | 1 ± 1 | 55 ± 12 | 0 | 0–0 |
Gemcitabine | 414 ± 49‡ | 9 ± 3‡ | 31 ± 12‡ | 1 | 0–3 |
AEE788 | 272 ± 52§ | 15 ± 5§ | 26 ± 5§ | 3 | 0–7 |
AEE788 + gemcitabine | 212 ± 51§ | 23 ± 6§ | 16 ± 6§ | 9 | 0–16§ |
Mean ± S.D. positive cells per field determined from measurement of 10 random 0.159-mm2 fields at x100 magnification.
Percentage of CD31/TUNEL+ cells in 10 random 0.011-mm2 fields at x400 magnification.
P < .01 vs control.
P < .001 vs control.